SCHEMBL8619909

SCHEMBL8619909

COc1cccc2nc(-c3ccccc3C)cc(C(=O)NC(=N)N)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 2/20 0.46
ALDH1A1 P00352 6/20 0.43
HPGD P15428 5/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
HTT P42858 2/20 0.43
MAPT P10636 1/20 0.43
GPR55 Q9Y2T6 1/20 0.43
POLB P06746 3/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
KMT2A Q03164 5/20 0.42
MEN1 O00255 4/20 0.42
LMNA P02545 3/20 0.42
KDM4E B2RXH2 4/20 0.42
DHODH Q02127 2/20 0.41
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8613229 0.89 TACR3 (0.44) TACR3ALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL8620874 0.89 ALDH1A1 (0.47) TACR3ALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL8615338 0.89 MEN1 (0.46) TACR3ALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL8615485 0.89 TACR3 (0.41) TACR3ALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL8618951 0.89 CA2 (0.44) TACR3ALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL8620377 0.88 CA2 (0.47) TACR3ALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL8620350 0.88 CA2 (0.43) TACR3ALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL8619971 0.88 TACR3 (0.42) TACR3ALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL8618517 0.88 KMT2A (0.43) TACR3ALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL8617295 0.87 CA12 (0.43) TACR3ALDH1A1HPGDSMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed